The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Cytomegalovirus infection in transplant recipients
Open accessAbstract
Cytomegalovirus infection is a frequent complication after transplantation. This infection occurs due to transmission from the transplanted organ, due to reactivation of latent infection, or after a primary infection in seronegative patients and can be defined as follows: latent infection, active infection, viral syndrome or invasive disease. This condition occurs mainly between 30 and 90 days after transplantation. In hematopoietic stem cell transplantation in particular, infection usually occurs within the first 30 days after transplantation and in the presence of graft-versus-host disease. The major risk factors are when the recipient is cytomegalovirus seronegative and the donor is seropositive as well as when lymphocyte-depleting antibodies are used. There are two methods for the diagnosis of cytomegalovirus infection: the pp65 antigenemia assay and polymerase chain reaction. Serology has no value for the diagnosis of active disease, whereas histology of the affected tissue and bronchoalveolar lavage analysis are useful in the diagnosis of invasive disease. Cytomegalovirus disease can be prevented by prophylaxis (the administration of antiviral drugs to all or to a subgroup of patients who are at higher risk of viral replication) or by preemptive therapy (the early diagnosis of viral replication before development of the disease and prescription of antiviral treatment to prevent the appearance of clinical disease). The drug used is intravenous or oral ganciclovir; oral valganciclovir; or, less frequently, valacyclovir. Prophylaxis should continue for 90 to 180 days. Treatment is always indicated in cytomegalovirus disease, and the gold-standard drug is intravenous ganciclovir. Treatment should be given for 2 to 3 weeks and should be continued for an additional 7 days after the first negative result for viremia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Definitions of Cytomegalovirus Infection and Disease in Transplant Recipients
Ljungman, P., Griffiths, P., & Paya, C. (2002) · Clinical Infectious Diseases · doi:10.1086/339329 · Cited by 1,234
Seroprevalence of Cytomegalovirus Infection in the United States, 1988-1994
Staras, S. A. S., Dollard, S. C., Radford, K. W., Flanders, W. D., Pass, R. F., & Cannon, M. J. (2006) · Clinical Infectious Diseases · doi:10.1086/508173 · Cited by 1,007
Kotton, C. N., Kumar, D., Caliendo, A. M., Åsberg, A., Chou, S., Snydman, D. R., Allen, U., & Humar, A. (2010) · Transplantation · doi:10.1097/tp.0b013e3181cee42f · Cited by 965
Kotton, C. N., Kumar, D., Caliendo, A. M., Åsberg, A., Chou, S., Danziger-Isakov, L., & Humar, A. (2013) · Transplantation · doi:10.1097/tp.0b013e31829df29d · Cited by 758
Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments
Gandhi, M. K., & Khanna, R. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01202-2 · Cited by 563
Cytomegalovirus in Solid Organ Transplantation
Razonable, R. R., & Humar, A. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12103 · Cited by 544
Humar, A., Lebranchu, Y., Vincenti, F., Blumberg, E. A., Punch, J. D., Limaye, A. P., Abramowicz, D., Jardine, A. G., Voulgari, A. T., Ives, J., et al. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2010.03074.x · Cited by 504
Humar, A., & Michaels, M. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.01207.x · Cited by 487
Quantitation of Cytomegalovirus: Methodologic Aspects and Clinical Applications
Boeckh, M., & Boivin, G. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.3.533 · Cited by 438
Boeckh, M., Nichols, W. G., Papanicolaou, G., Rubin, R., Wingard, J. R., & Zaia, J. (2003) · Biology of Blood and Marrow Transplantation · doi:10.1016/s1083-8791(03)00287-8 · Cited by 431
Cited by
Immunobiology of Human Cytomegalovirus: from Bench to Bedside
Crough, T., & Khanna, R. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00034-08 · Cited by 644
Cytomegalovirus Latency and Reactivation: An Intricate Interplay With the Host Immune Response
Forte, E., Zhang, Z., Thorp, E. B., & Hummel, M. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00130 · Cited by 256
RETRACTED: New intranasal and injectable gene therapy for healthy life extension
Jaijyan, D. K., Selariu, A., Cruz-Cosme, R., Tong, M., Yang, S., Stefa, A., Kekich, D., Sadoshima, J., Herbig, U., Tang, Q., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2121499119 · Cited by 57
Retracted
Metadata
- Authors
- Azevedo, L. S., Pierrotti, L. C., Abdala, E., Costa, S. F., Strabelli, T. M. V., Campos, S. V., Ramos, J. F., Latif, A. Z. A., Litvinov, N., Maluf, N. Z., Filho, H. H. C., Pannuti, C. S., Lopes, M. H., dos Santos, V. A., da Cruz Gouveia Linardi, C., Yasuda, M. A. S., & de Sousa Marques, H. H.
- Venue
- Clinics
- Publisher
- Elsevier BV
- Published
- 2015-07
- Volume
- 70
- Issue
- 7
- Pages
- 515-523
- ISSN
- 1807-5932 (ISSN-L)
- OpenAlex
- W1506247664
- Cited by
- 334
- References
- 38
- FWCI
- 9.17
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cytomegalovirus infection in transplant recipients. https://app.cochat.ai/papers/10.6061/clinics/2015(07)09
- The paper
- Azevedo, L. S., Pierrotti, L. C., Abdala, E., Costa, S. F., Strabelli, T. M. V., Campos, S. V., Ramos, J. F., Latif, A. Z. A., Litvinov, N., Maluf, N. Z., Filho, H. H. C., Pannuti, C. S., Lopes, M. H., dos Santos, V. A., da Cruz Gouveia Linardi, C., Yasuda, M. A. S., & de Sousa Marques, H. H. (2015). Cytomegalovirus infection in transplant recipients. Clinics. https://doi.org/10.6061/clinics/2015(07)09
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.